MARKET

RCDTF

RCDTF

Recordati Industria Chimica Ef
OTCPK
60.00
NaN%
Closed 09:30 06/12 EDT
OPEN
--
PREV CLOSE
60.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
60.00
52 WEEK LOW
49.00
MARKET CAP
12.21B
P/E (TTM)
22.58
1D
5D
1M
3M
1Y
5Y
1D
Recordati Sells Treasury Shares to Satisfy Stock Option Exercises
TipRanks · 06/05 16:24
Recordati’s Main Shareholder Backs CVC‑Led Bid to Delist Drugmaker from Euronext Milan
TipRanks · 05/27 19:32
Recordati Accelerates Performance Share Plan Ahead of Delisting Bid
TipRanks · 05/27 18:23
Respighi BidCo concert parties lift stakes in Recordati during takeover bid
TipRanks · 05/27 17:14
Bid Consortium Tightens Grip on Recordati With Fresh Share Purchases
TipRanks · 05/22 18:12
Respighi BidCo launches premium tender offer to take Recordati private and delist from Euronext Milan
TipRanks · 05/22 06:39
CVC and GBL launch €10.7bn bid to take Recordati private
TipRanks · 05/22 05:28
Recordati reports Q1 results
Seeking Alpha · 05/13 12:47
More
About RCDTF
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Webull offers Recordati Industria Chmc Frmctc SpA stock information, including OTCPK: RCDTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RCDTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RCDTF stock methods without spending real money on the virtual paper trading platform.